Study endpoints
The primary endpoint of this study was a composite of major adverse cardiac and cerebrovascular events (defined as ischemic stroke, hemorrhagic stroke, TIA, cardiovascular events including hospitalization for heart failure, acute coronary syndrome, and other cardiovascular events and all-cause death). Such events occurring within 3 months after the procedure were considered procedure-related adverse events and were excluded from the endpoint.